The incidence of Clostridium difficile-associated and non-C. difficile-associated diarrhea after use of gatifloxacin and levofloxacin in an acute-care facility.
Khurana
Aman
A
Vinayek
Namita
N
Recco
Rose A
RA
Go
Eddie S
ES
Zaman
Muhammad M
MM
D016360:Clostridioides difficile / Q000302:isolation & purification*; D003015:Clostridium Infections / Q000150:complications* / Q000188:drug therapy*; D003967:Diarrhea / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control*; D004632:Emergency Medical Services / Q000639:trends*; D024841:Fluoroquinolones / Q000627:therapeutic use*; D000077734:Gatifloxacin; D006801:Humans; D015994:Incidence; D064704:Levofloxacin; D015242:Ofloxacin / Q000627:therapeutic use*
D024841:Fluoroquinolones; D064704:Levofloxacin; D015242:Ofloxacin; D000077734:Gatifloxacin